Acrivon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	41.9	39.82	36.02	29.52	99.6	1.58
Short-Term Investments	95.53	139.66	91.44	98.23	-	-
Cash & Short-Term Investments	137.42	179.48	127.46	127.75	99.6	1.58
Cash Growth	-23.88%	40.81%	-0.23%	28.26%	6192.04%	-
Prepaid Expenses	0.99	2.15	2.23	4.34	0.81	0.14
Total Current Assets	138.41	181.63	129.69	132.1	100.41	1.72
Property, Plant & Equipment	8.12	8.03	7.91	6.86	5.79	0.06
Long-Term Investments	10.2	5.09	-	41.88	-	-
Long-Term Deferred Charges	-	0.5	-	-	-	-
Other Long-Term Assets	1.85	1.35	0.67	0.39	0.39	0.41
Total Assets	158.58	196.59	138.27	181.23	106.59	2.19
Accounts Payable	1.16	0.76	5.05	0.9	0.96	0.14
Accrued Expenses	10.56	15.4	7.38	4.14	1.22	0.42
Short-Term Debt	-	-	-	-	-	0.06
Current Portion of Leases	1.15	1.06	0.88	0.73	0.66	-
Current Unearned Revenue	-	-	-	0.07	0.07	-
Other Current Liabilities	0.57	-	-	0.67	-	-
Total Current Liabilities	13.43	17.21	13.3	6.52	2.91	0.61
Long-Term Leases	2.12	2.59	3.77	4.24	4.96	-
Total Liabilities	15.55	19.8	17.07	10.75	7.88	0.61
Common Stock	0.03	0.03	0.02	0.02	0	0
Additional Paid-In Capital	380.56	373.28	237.68	226.58	1.05	0.21
Retained Earnings	-237.66	-196.98	-116.42	-56.03	-24.87	-8.62
Comprehensive Income & Other	0.11	0.45	-0.08	-0.1	-	-
Total Common Equity	143.04	176.79	121.2	170.48	-23.81	-8.41
Shareholders' Equity	143.04	176.79	121.2	170.48	98.71	1.57
Total Liabilities & Equity	158.58	196.59	138.27	181.23	106.59	2.19
Total Debt	3.26	3.65	4.64	4.96	5.63	0.06
Net Cash (Debt)	134.16	175.84	122.81	122.79	93.98	1.53
Net Cash Growth	-23.91%	43.17%	0.02%	30.66%	6062.30%	-
Net Cash Per Share	3.50	5.20	5.56	29.79	53.90	1.06
Filing Date Shares Outstanding	31.46	31.35	22.64	21.92	1.77	1.43
Total Common Shares Outstanding	31.45	31.23	22.52	21.92	1.77	1.43
Working Capital	124.98	164.42	116.39	125.58	97.49	1.11
Book Value Per Share	4.55	5.66	5.38	7.78	-13.45	-5.87
Tangible Book Value	143.04	176.79	121.2	170.48	-23.81	-8.41
Tangible Book Value Per Share	4.55	5.66	5.38	7.78	-13.45	-5.87
Machinery	6.58	6.38	3.13	2.51	0.35	0.08
Construction In Progress	1.1	0.06	1.31	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q